LUNG

Pulmonx Corp

1.83

Oct 23 • 3:59 PM ET -0.05 (-2.66%)

1.83

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Micro NASD

Peers: INGN INSP ELMD VMD NYXH PRCT CV XAIR LIVN MDT

| Held by: VTI VXF IWC BUSM AVSC DFMC BTEC

Scroll to Statements

Index	-
Market Cap	78.60M
Enterprise Value	78.71M
Income	-48.12M
Sales	87.44M
Book/sh	0.91
Cash/sh	1.31
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	296
IPO	Oct 01, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	0.90
P/B	2.01
P/C	1.40
P/FCF	-
EV/EBITDA	-
EV/Sales	0.90
Quick Ratio	3.52
Current Ratio	4.32
Debt/Eq	1.43
LT Debt/Eq	1.40
Option/Short	Yes / Yes

EPS (ttm)	-1.16
EPS next Y	-0.94
EPS next Q	-0.26
EPS this Y	21.50%
EPS next Y	9.78%
EPS next 5Y	16.56%
EPS past 3/5Y	5.81% -8.01%
Sales past 3/5Y	19.03% 22.55%
EPS Y/Y TTM	19.16%
Sales Y/Y TTM	-3.43%
EPS Q/Q	36.74%
Sales Q/Q	-4.62%
Earnings	Oct 27 AMC
EPS/Sales Surpr.	14.29% 1.62%

Insider Own	10.48%
Insider Trans	-3.67%
Inst Own	61.11%
Inst Trans	-12.90%
ROA	-36.74%
ROE	-88.87%
ROIC	-51.17%
Gross Margin	76.71%
Oper. Margin	-52.96%
Profit Margin	-55.03%
SMA20	-0.60%
SMA50	-9.90%
SMA200	11.37%
Trades

Shs Outstand	42.95M
Shs Float	38.45M
Short Float	2.09%
Short Ratio	1.65
Short Interest	0.80M
52W High	2.89 -36.68%
52W Low	1.13 61.95%
Volatility	4.16% 5.66%
ATR (14)	0.11
RSI (14)	46.68
Beta	0.29
Rel Volume	0.47
Avg Volume	487.21K
Volume	227,772

Perf Week	2.81%
Perf Month	-3.68%
Perf Quarter	50.00%
Perf Half Y	44.09%
Perf YTD	-17.19%
Perf Year	15.09%
Perf 3Y	-78.67%
Perf 5Y	-95.37%
Perf 10Y	-
Recom	1.80
Target Price	3.40
Prev Close	1.88
Price	1.83
Change %	-2.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-25	Downgrade	Piper Sandler	Overweight → Neutral	$2.50
Mar-10-25	Initiated	D. Boral Capital	Buy	$17
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$17 → $7.50
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49

Show Previous Ratings

Oct-13-26 04:05PM	Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026 (GlobeNewswire)
Sep-03-26 08:28AM	Pulmonx Shares Fall Following Recent Gains (InvestorsHub)
Sep-01-26 04:05PM	Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.88%
Aug-27-26 04:05PM	Pulmonx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-29-26 04:05PM	Pulmonx Reports Second Quarter 2026 Financial Results (GlobeNewswire) +28.80%
04:05PM	Loading…
Jul-28-26 04:05PM	Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-15-26 04:05PM	Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026 (GlobeNewswire)
Jun-01-26 04:05PM	Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-30-26 03:17AM	Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com) +6.67%
Apr-29-26 04:05PM	Pulmonx Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-28-26 04:05PM	Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference (GlobeNewswire)
Apr-15-26 04:05PM	Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026 (GlobeNewswire) +5.63%
Mar-05-26 12:02AM	Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... (GuruFocus.com) +11.81%
Mar-04-26 07:00PM	Pulmonx Q4 Earnings Call Highlights (MarketBeat) -5.88%
05:35PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Loading…
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Closing of up to $60 Million Credit Facility (GlobeNewswire)
Feb-27-26 08:15AM	Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates (Zacks)
Feb-26-26 08:15AM	Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-20-26 08:00AM	Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 (GlobeNewswire) +5.99%
Dec-03-25 04:05PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.00% +13.23%
Nov-13-25 12:01AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... (GuruFocus.com) -18.88%
Nov-12-25 05:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.22%
04:05PM	Pulmonx Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:15PM	American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.01%
Oct-31-25 05:43AM	Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? (Insider Monkey) +13.64%
Oct-28-25 10:03AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +26.92%
Oct-27-25 04:05PM	Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 (GlobeNewswire)
Oct-15-25 04:05PM	Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 (GlobeNewswire)
Aug-27-25 12:00PM	What Makes Pulmonx (LUNG) a New Buy Stock (Zacks) +5.08%
04:05PM	Loading…
Aug-26-25 04:05PM	Pulmonx to Participate in September Investor Conferences (GlobeNewswire) +5.99%
Aug-11-25 05:00AM	Apreo raises $130M for pivotal trial of emphysema device (MedTech Dive)
Aug-05-25 09:35AM	After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) (Zacks)
Jul-31-25 03:33AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges (GuruFocus.com) -41.59%
Jul-30-25 06:00PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 04:05PM	Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
10:05AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-16-25 04:05PM	Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 (GlobeNewswire) +7.78% +6.19%
May-28-25 04:05PM	Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +8.11%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
May-01-25 04:05PM	Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire) -21.95%
10:06AM	Q1 2025 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... (GuruFocus.com)
Apr-30-25 08:25PM	Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript (Seeking Alpha) -8.35%
06:10PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 04:05PM	Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025 (GlobeNewswire) -5.64%
06:53AM	P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Feb-20-25 01:14PM	Q4 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +32.23%
02:12AM	Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com)
Feb-19-25 05:20PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.01%
04:05PM	Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
04:58AM	What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 04:05PM	Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day (GlobeNewswire) +5.28% -5.56%
Feb-05-25 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire) +6.59%
Nov-21-24 09:55AM	Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? (Zacks)
Nov-20-24 04:05PM	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 09:00AM	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers (Business Wire)
Nov-07-24 04:05PM	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-24 04:05PM	Pulmonx to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire) +8.44%
09:55AM	Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know (Zacks)
Oct-31-24 07:00AM	Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com) -7.95%
Oct-30-24 06:25PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 04:05PM	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire) -5.74%
Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
French Glendon E. III	President and CEO	Sep 01 '26	Sale	2.26	41,882	94,653	1,137,936	Sep 03 06:23 PM
Radhakrishnan Srikanth	Chief Science & Techn. Officer	Sep 01 '26	Sale	2.26	14,245	32,194	316,994	Sep 03 06:21 PM
Lehman David Aaron	General Counsel	Sep 01 '26	Sale	2.26	14,334	32,395	361,827	Sep 03 06:19 PM
Rose Geoffrey Beran	Chief Commercial Officer	Sep 01 '26	Sale	2.26	7,879	17,807	449,832	Sep 03 06:17 PM
Radhakrishnan Srikanth	Chief Science &Techn. Officer	Jun 01 '26	Sale	1.54	14,497	22,325	331,239	Jun 03 04:18 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 01 '26	Sale	1.54	14,594	22,475	376,161	Jun 03 04:17 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 01 '26	Sale	1.54	8,023	12,355	457,711	Jun 03 04:16 PM
French Glendon E. III	President and CEO	Jun 01 '26	Sale	1.54	42,638	65,663	1,191,673	Jun 03 04:15 PM
French Glendon E. III	President and CEO	Jun 02 '26	Sale	1.57	13,511	21,212	1,178,162	Jun 03 04:15 PM
Radhakrishnan Srikanth	Chief Science &Techn. Officer	Mar 02 '26	Sale	1.43	10,483	14,991	170,736	Mar 04 07:07 PM
French Glendon E. III	President and CEO	Mar 02 '26	Sale	1.43	67,813	96,973	1,409,511	Mar 04 07:06 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 02 '26	Sale	1.43	7,732	11,057	365,734	Mar 04 07:04 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 02 '26	Sale	1.43	12,237	17,499	240,755	Mar 04 07:01 PM
STEVEN WILLIAMSON	Officer	Jan 22 '26	Proposed Sale	1.95	48,892	95,339		Jan 22 04:02 PM
STEVEN WILLIAMSON	Officer	Jan 15 '26	Proposed Sale	1.95	15,892	31,039		Jan 15 05:49 PM
STEVEN WILLIAMSON	Officer	Jan 14 '26	Proposed Sale	2.00	31,082	62,074		Jan 14 05:13 PM
Florin Daniel P	Director	Dec 08 '25	Sale	1.99	23,321	46,409	93,910	Dec 09 05:59 PM
DANIEL P FLORIN	Director	Dec 08 '25	Proposed Sale	1.99	23,321	46,385		Dec 08 06:26 PM
French Glendon E. III	President and CEO	Dec 01 '25	Sale	1.57	8,805	13,824	277,324	Dec 03 07:51 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Dec 01 '25	Sale	1.57	6,322	9,926	373,466	Dec 03 07:48 PM
Lehman David Aaron	GENERAL COUNSEL	Dec 01 '25	Sale	1.57	10,278	16,136	252,992	Dec 03 07:43 PM

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the following geographical segments: United States, Europe, Middle East, Africa, Asia Pacific, and Other International. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

CEOMr. Glendon E. French

CFO & COODr. Derrick Sung Ph.D.

General Counsel & SecretaryMr. David A. Lehman J.D.

Chief Science & Technology OfficerMr. Srikanth Radhakrishnan

Vice President of MarketingMs. Marcee M. Maroney

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LUNG

Pulmonx Corp

Upgrade your Finviz experience